絞り込み

16525

広告

珍しい中型ティラノサウルス類の骨?…北海道 (読売新聞)

北海道大学は20日、北海道芦別市の白亜紀後期(約1億年~約6600万年前)の地層から見つかった恐竜の化石が、ティラノサウルス類の尾の骨である可能性が高いことが分...

  1. なぜ博士キャラは「〜じゃ」と話すの?リア...
  2. 【書評】中国のSF作家はどれだけ未来を見...
  3. エタノールから酢酸 合成方法を開発 (毎...
  4. DNAで恋が芽生える!新時代の婚活サービ...

ニュース一覧

スターを付ける スターを付ける     (33view , 0users)

Full Text Sources

Drug nanocrystals (NCs) with fascinating physicochemical properties have attracted great attention in drug delivery. High drug-loading efficiency, great structural stability, steady dissolution, and long circulation time are a few examples of these properties, which makes drug NCs an excellent formulation for efficient cancer therapy. In the last two decades, there are a lot of hydrophobic or lipophilic drugs, such as paclitaxel (PTX), camptothecin (CPT), thymectacin, busulfan, cyclosporin A, 2-devinyl-2-(1-hexyloxyethyl) pyropheophorbide (HPPH), and so on, which have been formulated into drug NCs for cancer therapy. In this review, we summarized the recent advances in drug NCs-based cancer treatment. So far, there are main three methods to synthesize drug NCs, including top-down, bottom-up, and combination methods. The characterization methods of drug NCs were also elaborated. Furthermore, the applications and mechanisms of drug NCs were introduced by their administration routes. At the end, we gave a brief conclusion and discussed the future perspectives of drug NCs in cancer therapy. For further resources related to this article, please visit the WIREs website.
PMID: 29044971 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード